VNDA Vanda Pharmaceuticals Inc.

Fundamentals / CIK 0001347178 / USD

Vanda Pharmaceuticals Inc. reported $229.3M in revenue and a net loss of $274.8M for the trailing twelve months ended September 30, 2026 (up 24.1% year over year), with a 93.6% gross margin and a -77.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VNDA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$288.1M$144.0M$0-$229.0MFY 2016 Revenue: $146.0MFY 2016 Net Income: -$18.01M2016FY 2017 Revenue: $165.1MFY 2017 Net Income: -$15.57M2017FY 2018 Revenue: $193.1MFY 2018 Net Income: $25.21M2018FY 2019 Revenue: $227.2MFY 2019 Net Income: $115.6M2019FY 2020 Revenue: $248.2MFY 2020 Net Income: $23.34M2020FY 2021 Revenue: $268.7MFY 2021 Net Income: $33.15M2021FY 2022 Revenue: $254.4MFY 2022 Net Income: $6.28M2022FY 2023 Revenue: $192.6MFY 2023 Net Income: $2.51M2023FY 2024 Revenue: $198.8MFY 2024 Net Income: -$18.90M2024FY 2025 Revenue: $216.1MFY 2025 Net Income: -$220.5M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $216.1M $198.8M $192.6M $254.4M $268.7M $248.2M $227.2M $193.1M $165.1M $146.0M
Cost of Revenue $13.04M $11.31M $14.80M $24.28M $25.63M $23.36M $24.49M $20.51M -- --
Gross Profit $203.1M $187.5M $177.8M $230.1M $243.1M $224.8M $202.7M $172.6M -- --
Research & Development $109.3M $74.43M $76.82M $85.77M $75.36M $55.58M $48.65M $43.59M $38.55M $29.16M
Selling, General & Admin $238.0M $146.4M $112.9M $136.5M $124.0M $140.5M $129.7M $105.8M $123.8M $99.79M
Operating Income -$151.2M -$40.66M -$13.95M $6.33M $42.16M $27.24M $22.81M $21.74M -$16.90M -$18.57M
EBITDA -$143.1M -$32.53M -$10.94M $9.06M $45.01M $30.10M $25.70M $24.69M -$13.92M -$6.70M
Income Before Tax -$138.6M -$22.92M $6.34M $11.30M $42.36M $31.66M $29.03M $25.35M -$15.43M -$17.91M
Income Tax Expense $81.83M -$4.02M $3.83M $5.03M $9.21M $8.32M -$86.53M $138K $136K $104K
Net Income -$220.5M -$18.90M $2.51M $6.28M $33.15M $23.34M $115.6M $25.21M -$15.57M -$18.01M
Basic EPS -$3.74 -$0.33 $0.04 $0.11 $0.60 $0.43 $2.17 $0.50 -$0.35 -$0.41
Diluted EPS -$3.74 -$0.33 $0.04 $0.11 $0.58 $0.42 $2.11 $0.48 -$0.35 -$0.41
Basic Shares Outstanding 58.9M 58.1M 57.4M 56.5M 55.5M 54.4M 53.1M 50.9M 44.7M 43.4M
Diluted Shares Outstanding 58.9M 58.1M 57.6M 57.0M 56.9M 55.2M 54.8M 53.0M 44.7M 43.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $69.81M $50.53M $51.72M $57.22M $56.26M $52.59M $50.04M $53.19M
Cost of Revenue $4.15M $3.56M $3.16M $3.83M $2.95M $2.74M $3.52M $2.59M
Gross Profit $65.66M $46.97M $48.56M $53.38M $53.30M $49.85M $46.52M $50.59M
Research & Development $27.62M $36.95M $28.43M $29.01M $22.56M $21.99M $35.71M $19.84M
Selling, General & Admin $59.58M $71.84M $68.36M $62.98M $60.27M $64.62M $50.08M $39.28M
Operating Income -$23.52M -$63.81M -$50.22M -$40.35M -$31.28M -$38.50M -$41.03M -$10.28M
EBITDA -$21.29M -$61.55M -$47.96M -$38.30M -$29.23M -$36.48M -$39.05M -$8.31M
Income Before Tax -$22.39M -$62.38M -$48.42M -$38.00M -$28.39M -$34.89M -$37.37M -$6.50M
Income Tax Expense $174K $129K $143K $103.2M -$5.80M -$7.68M -$7.87M -$1.58M
Net Income -$22.56M -$62.51M -$48.57M -$141.2M -$22.59M -$27.21M -$29.49M -$4.91M
Basic EPS -$0.37 -$1.04 -$0.82 -- -$0.38 -$0.46 -$0.50 --
Diluted EPS -$0.37 -$1.04 -$0.82 -- -$0.38 -$0.46 -$0.50 --
Basic Shares Outstanding 60.5M 60.2M 59.5M -- 59.1M 59.0M 58.5M --
Diluted Shares Outstanding 60.5M 60.2M 59.5M -- 59.1M 59.0M 58.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $84.85M $102.3M $135.8M $135.0M $52.07M $61.03M $45.07M $61.01M $33.63M $40.43M
Short-Term Investments -- -- -- -- $380.7M $306.7M $267.1M $196.4M $109.8M $100.9M
Cash & Short-Term Investments $84.85M $102.3M $135.8M $135.0M $432.8M $367.7M $312.1M $257.4M $143.4M $141.3M
Accounts Receivable, Net $54.58M $47.10M $34.16M $33.51M $32.47M $30.04M $26.37M $28.78M $17.60M $20.27M
Inventory $1.85M $1.73M $1.36M $1.19M $1.02M $1.28M $1.14M $994K $840K $779K
Other Current Assets -- -- -- -- -- -- -- -- $2.71M $1.58M
Total Current Assets $347.3M $438.9M $432.9M $519.3M $478.3M $409.1M $354.1M $299.1M $169.9M $174.2M
Property, Plant & Equipment, Net $2.25M $2.13M $2.04M $2.57M $3.11M $4.14M $3.86M $4.42M $5.31M $5.01M
Intangible Assets $117.1M $114.1M $121.4M $18.57M $20.08M $21.56M $23.04M $24.54M $26.07M $27.82M
Long-Term Investments -- -- -- -- -- -- -- $0 -- --
Total Non-Current Assets $141.7M $217.3M $215.5M $115.0M $115.5M $124.3M $129.6M $33.00M $35.57M $36.20M
Total Assets $488.9M $656.2M $648.4M $634.2M $593.8M $533.5M $483.7M $332.1M $205.4M $210.4M
Total Current Liabilities $145.2M $99.98M $87.70M $91.44M $74.42M $65.94M $59.51M $53.02M $70.36M $50.32M
Other Non-Current Liabilities $9.53M $9.59M $8.83M $6.80M $4.39M $2.76M $843K $3.69M $3.67M $3.72M
Total Non-Current Liabilities $16.60M $17.68M $15.83M $15.61M $14.45M $14.25M $13.30M $3.69M $3.67M $28.72M
Total Liabilities $161.8M $117.7M $103.5M $107.0M $88.86M $80.19M $72.80M $56.71M $74.04M $79.04M
Total Debt (incl. Leases) $12.62M $12.36M $9.40M $11.14M $12.37M $13.61M $14.60M -- -- --
Common Stock $59K $58K $58K $57K $56K $55K $54K $52K $45K $44K
Retained Earnings -$394.8M -$174.3M -$155.4M -$157.9M -$164.2M -$197.3M -$220.7M -$336.2M -$361.4M -$345.9M
Accumulated Other Comp. Income $629K $74K -$30K -$1.19M -$175K $239K $249K $1.0K -$34K $58K
Total Stockholders' Equity $327.2M $538.5M $544.9M $527.2M $504.9M $453.3M $410.9M $275.4M $131.4M $131.3M
Total Equity $327.2M $538.5M $544.9M $527.2M $504.9M $453.3M $410.9M $275.4M $131.4M $131.3M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $61.93M $55.88M $54.03M $84.85M $70.02M $80.98M $111.8M $102.3M
Cash & Short-Term Investments $61.93M $55.88M $54.03M $84.85M $70.02M $80.98M $111.8M $102.3M
Accounts Receivable, Net $60.32M $59.69M $56.88M $54.58M $50.54M $44.99M $44.60M $47.10M
Inventory $1.53M $1.68M $1.70M $1.85M $2.04M $2.17M $1.92M $1.73M
Total Current Assets $238.5M $264.5M $293.2M $347.3M $367.5M $394.9M $407.9M $438.9M
Property, Plant & Equipment, Net $3.03M $2.58M $2.25M $2.25M $2.46M $2.42M $2.44M $2.13M
Intangible Assets $111.1M $113.1M $115.1M $117.1M $108.8M $110.6M $112.3M $114.1M
Total Non-Current Assets $143.9M $148.0M $140.4M $141.7M $233.6M $229.8M $224.0M $217.3M
Total Assets $382.3M $412.5M $433.5M $488.9M $601.1M $624.7M $631.9M $656.2M
Total Current Liabilities $155.0M $164.0M $135.6M $145.2M $117.9M $121.5M $103.9M $99.98M
Other Non-Current Liabilities $10.20M $10.05M $10.13M $9.53M $11.04M $9.97M $9.24M $9.59M
Total Non-Current Liabilities $27.49M $28.26M $17.18M $16.60M $17.27M $16.93M $16.60M $17.68M
Total Liabilities $182.5M $192.3M $152.8M $161.8M $135.1M $138.4M $120.5M $117.7M
Total Debt (incl. Leases) $21.97M $22.83M $13.07M $12.62M $10.91M $11.64M $11.74M $12.36M
Common Stock $60K $60K $60K $59K $59K $59K $59K $58K
Retained Earnings -$528.4M -$505.8M -$443.3M -$394.8M -$253.6M -$231.0M -$203.8M -$174.3M
Accumulated Other Comp. Income -$66K $38K $212K $629K $540K $396K $383K $74K
Total Stockholders' Equity $199.9M $220.2M $280.8M $327.2M $466.0M $486.3M $511.4M $538.5M
Total Equity $199.9M $220.2M $280.8M $327.2M $466.0M $486.3M $511.4M $538.5M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$220.5M -$18.90M $2.51M $6.28M $33.15M $23.34M $115.6M $25.21M -$15.57M -$18.01M
Depreciation & Amortization $8.11M $8.13M $3.01M $2.73M $2.84M $2.86M $2.89M $2.96M $2.98M $11.87M
Stock-Based Compensation $9.47M $12.43M $14.04M $16.28M $15.37M $13.36M $13.46M $11.67M $10.46M $8.54M
Change in Receivables -$7.46M -$13.01M -$707K -$1.09M -$2.47M -$3.77M $2.34M -$11.21M $2.52M -$4.30M
Change in Inventory -$3.47M -$29K -$771K -$4.48M -$2.23M -$2.88M -$722K $70K -$1.06M $200K
Operating Cash Flow -$109.4M -$15.76M $12.80M $31.98M $64.21M $51.77M $45.95M $29.99M -$1.98M -$8.10M
Capital Expenditure -$998K -$490K -$383K -$679K -$552K -$1.79M -$1.02M -$368K -$1.66M -$1.41M
Free Cash Flow -$110.4M -$16.25M $12.42M $31.30M $63.66M $49.98M $44.93M $29.62M -$3.65M -$9.51M
Purchases of Investments -$112.4M -$364.8M -$512.6M -$349.3M -$420.5M -$346.6M -$394.5M -$282.4M -$148.1M -$165.4M
Investing Cash Flow $94.86M -$17.43M -$12.06M $49.92M -$76.70M -$41.50M -$68.31M -$109.7M -$10.23M -$10.03M
Common Stock Issued -- -- -- -- -- $0 $0 $100.9M $0 $0
Financing Cash Flow -$2.91M -$155K $0 $734K $3.55M $5.63M $6.26M $107.1M $5.25M $7.75M
Net Change in Cash -$17.46M -$33.51M $792K $82.91M -$9.02M $15.96M -$16.10M $27.41M -$6.92M -$10.37M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$22.56M -$62.51M -$48.57M -$141.2M -$22.59M -$27.21M -$29.49M -$4.91M
Depreciation & Amortization $2.23M $2.25M $2.26M $2.06M $2.05M $2.02M $1.98M $1.97M
Stock-Based Compensation $2.34M $2.11M $2.56M $2.29M $2.11M $2.11M $2.97M $2.86M
Change in Receivables -$654K -$2.80M -$2.33M -$4.08M -$5.57M -$353K $2.53M -$4.43M
Change in Inventory $133K -$97K $294K -$1.28M $32K -$368K -$1.85M -$107K
Operating Cash Flow -$28.43M -$31.07M -$50.22M -$29.42M -$31.63M -$15.25M -$33.15M -$1.82M
Capital Expenditure -$311K -$190K -$221K -$102K -$161K -$299K -$436K -$214K
Free Cash Flow -$28.75M -$31.26M -$50.44M -$29.52M -$31.79M -$15.55M -$33.58M -$2.03M
Purchases of Investments $0 $0 $0 -$2.03M -$14.05M -$52.97M -$43.33M -$92.40M
Investing Cash Flow $35.21M $33.81M $20.23M $44.87M $21.36M -$15.27M $43.90M $3.99M
Financing Cash Flow -$877K -$856K -$776K -$640K -$517K -$425K -$1.32M -$155K
Net Change in Cash $5.95M $1.85M -$30.82M $14.83M -$10.96M -$30.81M $9.48M $1.82M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 94.0% 94.3% 92.3% 90.5% 90.5% 90.6% 89.2% 89.4% -- --
Operating Margin -70.0% -20.5% -7.2% 2.5% 15.7% 11.0% 10.0% 11.3% -10.2% -12.7%
Net Profit Margin -102.0% -9.5% 1.3% 2.5% 12.3% 9.4% 50.9% 13.1% -9.4% -12.3%
Return on Equity (ROE) -67.4% -3.5% 0.5% 1.2% 6.6% 5.1% 28.1% 9.2% -11.8% -13.7%
Return on Assets (ROA) -45.1% -2.9% 0.4% 1.0% 5.6% 4.4% 23.9% 7.6% -7.6% -8.6%
Current Ratio 2.39x 4.39x 4.94x 5.68x 6.43x 6.21x 5.95x 5.64x 2.41x 3.46x
Quick Ratio 2.38x 4.37x 4.92x 5.67x 6.41x 6.19x 5.93x 5.62x 2.40x 3.45x
Debt to Equity 0.04x 0.02x 0.02x 0.02x 0.02x 0.03x 0.04x -- -- --
Revenue Growth (YoY) +8.7% +3.2% -24.3% -5.3% +8.3% +9.2% +17.6% +17.0% +13.1% +32.8%
Gross Profit Growth (YoY) +8.3% +5.4% -22.7% -5.3% +8.1% +10.9% +17.4% -- -- --
Operating Income Growth (YoY) -- -- -320.4% -85.0% +54.8% +19.4% +4.9% -- -- --
Net Income Growth (YoY) -- -853.3% -60.0% -81.1% +42.1% -79.8% +358.4% -- -- --
EPS Growth (YoY) -- -925.0% -63.6% -81.7% +39.5% -80.2% +334.0% -- -- --
Operating Cash Flow Growth (YoY) -- -223.1% -60.0% -50.2% +24.0% +12.7% +53.2% -- -- -165.1%
Free Cash Flow Growth (YoY) -- -230.8% -60.3% -50.8% +27.4% +11.2% +51.7% -- -- -195.8%
5Y Revenue / Share Growth -19.6% -20.0% -11.6% +22.1% +43.9% +75.3% +196.4% +240.2% +218.3% +202.1%
10Y Revenue / Share Growth +40.9% +137.0% +200.8% +288.6% +334.8% +256.5% +2439.6% -- -- --
5Y Net Income / Share Growth -972.6% -114.9% -91.2% -- -- -- +274.6% -- -- --
10Y Net Income / Share Growth -- -156.0% -- -- -- +66.4% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 93.6% 93.7% 94.2% 94.0% 94.4% 94.4% 94.3% 94.3%
Operating Margin -77.6% -86.1% -73.6% -70.0% -57.1% -49.5% -36.0% -20.5%
Net Profit Margin -119.9% -127.4% -110.0% -102.0% -39.7% -32.9% -22.0% -9.5%
Return on Equity (ROE) -137.5% -124.8% -85.3% -67.4% -18.1% -13.8% -8.7% -3.5%
Return on Assets (ROA) -71.9% -66.6% -55.3% -45.1% -14.0% -10.7% -7.0% -2.9%
Current Ratio 1.54x 1.61x 2.16x 2.39x 3.12x 3.25x 3.93x 4.39x
Quick Ratio 1.53x 1.60x 2.15x 2.38x 3.10x 3.23x 3.91x 4.37x
Debt to Equity 0.11x 0.10x 0.05x 0.04x 0.02x 0.02x 0.02x 0.02x
Revenue Growth (YoY) +24.1% -3.9% +3.4% +7.6% +18.1% +4.2% +5.4% +17.5%
Gross Profit Growth (YoY) +23.2% -5.8% +4.4% +5.5% +18.2% +4.4% +5.7% +21.0%
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -537.9% --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -544.1% --
Source: SEC EDGAR CompanyFacts (CIK 0001347178) · from December 31, 2009 Data through September 30, 2026 · synced Nov 20, 2026, 05:42 UTC · Open in terminal